Amedeo's Top 20

Amedeo Smart

Independent Medical Education


19 April 2021

Multidisciplinary Journal Club

  1. Loibl S, Poortmans P, Morrow M, Denkert C, et al.
    Breast cancer.
    Lancet 2021.

  1. Solling AS, Harslof T, Langdahl B.
    Treatment with zoledronate subsequent to denosumab in osteoporosis: a 2-year randomized study.
    J Bone Miner Res 2021.

  2. Venturutti L, Melnick AM.
    The dangers of deja vu: memory B cells as the cells of origin of ABC-DLBCLs.
    Blood 2020;136:2263-2274.

  3. Lockman S, Brummel SS, Ziemba L, Stranix-Chibanda L, et al.
    Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in preg
    Lancet 2021;397:1276-1292.

  4. Gaudry S, Hajage D, Martin-Lefevre L, Lebbah S, et al.
    Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial.
    Lancet 2021;397:1293-1300.

  1. Advani R, Moskowitz AJ, Bartlett NL, Vose J, et al.
    Brentuximab vedotin in combination with nivolumab in relapsed or refractory Hodgkin lymphoma: 3-year study results.
    Blood 2021.

  2. Karschnia P, Batchelor TT, Jordan JT, Shaw B, et al.
    Primary dural lymphomas: Clinical presentation, management, and outcome.
    Cancer 2020;126:2811-2820.

  3. Fiest KM, Soo A, Hee Lee C, Niven DJ, et al.
    Long-Term Outcomes in Intensive Care Unit Patients with Delirium: A Population-Based Cohort Study.
    Am J Respir Crit Care Med 2021.

  4. Benesch C, Glance LG, Derdeyn CP, Fleisher LA, et al.
    Perioperative Neurological Evaluation and Management to Lower the Risk of Acute Stroke in Patients Undergoing Noncardiac, Nonneurological Surgery: A Scientific Statement From the American Heart Association/American Stroke Association.
    Circulation 2021.

  5. Rao R, Topiwala A.
    Alcohol use disorders and the brain.
    Addiction 2020;115:1580-1589.

  1. Chihara D, Dores G, Flowers C, Morton LM, et al.
    The bidirectional increased risk of B-cell lymphoma and T-cell lymphoma.
    Blood 2021.

  2. Hwang H, Kang H, Kwon YS, Jeon D, et al.
    Outcomes of multidrug-resistant tuberculosis treated with bedaquiline or delamanid.
    Clin Infect Dis 2021.

  3. Broman KK, Hughes T, Dossett L, Sun J, et al.
    Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy trial II (MSLT-2).
    Cancer 2021.

  4. Wada Y, Shimada M, Murano T, Takamaru H, et al.
    A Liquid Biopsy Assay for Noninvasive Identification of Lymph Node Metastases in T1 Colorectal Cancer.
    Gastroenterology 2021.

  5. Stahl E, Roda G, Dobbyn A, Hu J, et al.
    Collagenous Colitis Is Associated With HLA Signature and Shares Genetic Risks With Other Immune-Mediated Diseases.
    Gastroenterology 2020;159:549-561.e8.

  1. Pisa M, Croese T, Dalla Costa G, Guerrieri S, et al.
    Subclinical anterior optic pathway involvement in early multiple sclerosis and clinically isolated syndromes.
    Brain 2021.

  2. Chase DM, Neighbors J, Perhanidis J, Monk BJ, et al.
    Gastrointestinal symptoms and diagnosis preceding ovarian cancer diagnosis: Effects on treatment allocation and potential diagnostic delay.
    Gynecol Oncol 2021.

  3. Trojano M, Ramio-Torrenta L, Grimaldi LM, Lubetzki C, et al.
    A randomized study of natalizumab dosing regimens for relapsing-remitting multiple sclerosis.
    Mult Scler 2021.

  4. Khalili H, Hakansson N, Chan SS, Chen Y, et al.
    Adherence to a Mediterranean diet is associated with a lower risk of later-onset Crohn's disease: results from two large prospective cohort studies.
    Gut 2020;69:1637-1644.

  5. Gianotti N, Galli L, Poli A, Torre LD, et al.
    Residual viremia in HIV-infected patients who continue a 2-drug or switch to a 3-drug integrase strand transfer inhibitor-based regimen.
    AIDS 2021.


more..


Privacy Policy